Abstract
Serratia marcescens is an important nosocomial pathogen which is often resistant to multiple antimicrobial agents. An imipenem-resistant S. marcescens isolate from a urine specimen was found to carry a bla(VIM-2) gene cassette on a class 1 integron. This finding indicates that bla(VIM-2) is presently spreading even to Serratia spp. in Korea, which could compromise the usefulness of carbapenem in the treatment of multi-resistant Gram-negative bacilli infections. Clinical laboratory should be able to detect the VIM-2-producing isolates with even low carbapenem MIC.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Drug Resistance, Bacterial / genetics*
-
Drug Resistance, Multiple, Bacterial
-
Humans
-
Korea
-
Microbial Sensitivity Tests
-
Mutagenesis, Insertional
-
Polymerase Chain Reaction
-
Recombination, Genetic / genetics*
-
Serratia marcescens / drug effects
-
Serratia marcescens / enzymology*
-
Serratia marcescens / genetics*
-
Serratia marcescens / isolation & purification
-
beta-Lactamases / genetics*
-
beta-Lactams
Substances
-
Anti-Bacterial Agents
-
beta-Lactams
-
VIM-1 metallo-beta-lactamase
-
beta-Lactamases